406 related articles for article (PubMed ID: 15504124)
21. [In vitro antifungal activity of amorolfine, a new morpholine antimycotic agent].
Hiratani T; Asagi Y; Matsusaka A; Uchida K; Yamaguchi H
Jpn J Antibiot; 1991 Sep; 44(9):993-1006. PubMed ID: 1960861
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
[TBL] [Abstract][Full Text] [Related]
23. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
[TBL] [Abstract][Full Text] [Related]
24. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
[TBL] [Abstract][Full Text] [Related]
25. Determination of susceptibility/resistance to antifungal drugs of Trichophyton mentagrophytes isolates by a macrodilution method.
Barros ME; Hamdan JS
Can J Microbiol; 2005 Nov; 51(11):983-7. PubMed ID: 16333338
[TBL] [Abstract][Full Text] [Related]
26. Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection.
Ataides FS; Chaul MH; El Essal FE; Costa CR; Souza LK; Fernandes OF; Silva MR
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1479-85. PubMed ID: 22049990
[TBL] [Abstract][Full Text] [Related]
27. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.
Schaller M; Borelli C; Berger U; Walker B; Schmidt S; Weindl G; Jäckel A
Med Mycol; 2009 Nov; 47(7):753-8. PubMed ID: 19888808
[TBL] [Abstract][Full Text] [Related]
29. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of antifungal activity of Ononis spinosa L. ash used for the therapy of skin infections as folk remedies].
Altuner EM; Ceter T; Işlek C
Mikrobiyol Bul; 2010 Oct; 44(4):633-9. PubMed ID: 21063975
[TBL] [Abstract][Full Text] [Related]
31. In vitro fungistatic and fungicidal activities of silver sulfadiazine and natamycin on pathogenic fungi isolated from horses with keratomycosis.
Betbeze CM; Wu CC; Krohne SG; Stiles J
Am J Vet Res; 2006 Oct; 67(10):1788-93. PubMed ID: 17014335
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of panomycocin, a novel exo-beta-1,3-glucanase isolated from Pichia anomala NCYC 434, against dermatophytes.
Izgü F; Altinbay D; Türeli AE
Mycoses; 2007 Jan; 50(1):31-4. PubMed ID: 17302745
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G
J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
Citak S; Ozçelik B; Cesur S; Abbasoğlu U
Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
[TBL] [Abstract][Full Text] [Related]
37. Antifungal activity of Heterothalamus alienus metabolites.
Pacciaroni Adel V; Gette Mde L; Derita M; Ariza-Espinar L; Gil RR; Zacchino SA; Silva GL
Phytother Res; 2008 Apr; 22(4):524-8. PubMed ID: 18386258
[TBL] [Abstract][Full Text] [Related]
38. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
Carrillo-Muñoz AJ; Quindós G; Ruesga M; Brió S; del Valle O; Rodríguez V; Hernández-Molina JM; Cantón E; Pemán J; Santos P
Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
[TBL] [Abstract][Full Text] [Related]
39. What defines the quality of patient care in tinea pedis?
Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
[TBL] [Abstract][Full Text] [Related]
40. Antifungal activity of Andrographis paniculata extracts and active principles against skin pathogenic fungal strains in vitro.
Sule A; Ahmed QU; Latip J; Samah OA; Omar MN; Umar A; Dogarai BB
Pharm Biol; 2012 Jul; 50(7):850-6. PubMed ID: 22587518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
